Arrow Dx attends the 2018 J.P. Morgan Healthcare Conference
Blood Diagnostics with Nanoscale Precision
Arrow Diagnostics is developing highly sensitive diagnostic kits that can be incorporated into portable sensors. The versatility of this technology allows its use in a variety of environments.
The ability to detect small-molecules and proteins in blood is an important tool in the fight against disease. Arrow Diagnostics' technology can detect chemical and biological entities in the parts per billion range.
Protein conformational changes can be an important signal as to whether a medicine is working. Arrow Diagnostics is working on applying its technology to aid the development of biopharmaceuticals.
Our mission is to harness the powerful applications of machine learning and predictive analytics to enhance diagnostic medicine. Using proprietary algorithms we are working to develop single protein and metabolite sensitivity.
Our mission is to develop new tools to help researchers and doctors detect chemical and biological entities in the fight against disease.
We believe our technology is the key to unlocking fast, reliable , and flexible diagnostics for a wide variety of applications.
Timeline of Growth
Gyongyi Szabo, MD, PhD, Dept. of Medicine, UMass, Worcester, President of American Assoc. for Liver Diseases, & Andrea Tao, PhD, Associate Professor of Nanoengineering, University of California, San Diego join Arrow Dx as collaborators. Molly Schmid PhD, Entrepreneur in Residence at USC joins the Arrow Dx Board of Advisors.